TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 1 | 12 | 5 | -9 | -12 | -65 | -80 | -25 |
| P | %wins | 100 | 100 | 0 | 0 | 0 | 0 | 33 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/17/24 09:26 | 6/14/24 | SNDX | Syndax Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Goldan Keith A. | MA | O | CFO | P | 25 | 20.03 | 0 | 1 | 2 | 53 | D | ||||||||||||||
9/23/20 16:47 | 9/23/20 | OPTN | Optinose, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Goldan Keith A. | PA | O | CFO | P | 10 | 3.90 | 0 | 3 | 34 | 10 | D | ||||||||||||||
8/11/15 16:03 | 8/11/15 | FCSC | Fibrocell Science, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Goldan Keith A. | PA | O | SVP,CFO | P | 13 | 6.33 | 3 | 2 | New | 2 | D | 10 | 90 | 72 | 81 | 28 | 9 | 1 | -14 | 12 | 5 | -9 | -12 | -65 | -80 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |